Skip to main content
. 2015 Mar 25;5:72. doi: 10.3389/fonc.2015.00072

Table 4.

Effect sizes, means (and standard deviations) for psychosocial measures.

Measure dInt-Wait Time 1
Time 2
Time 3
T2/T3 Intervention (n = 15) Waitlist (n = 12) Community (n = 16) Intervention (n = 15) Waitlist (n = 12) Community (n = 16) Intervention (n = 15) Waitlist (n = 12)
QoL (QLQ–C30)
Physical −0.06/0.13 80.9 (24.9) 81.1 (18.4) 97.9 (4.0) 84.4 (17.6) 86.1 (10.4)* 98.3 (14.8) 88.9 (14.2) 86.1 (16.4)
Role 0.40/0.28 72.2 (27.2) 79.2 (23.7) 93.8 (14.8) 85.6 (29.5)* 81.9 (19.4) 96.9 (9.1) 81.1 (32.0) 80.6 (15.6)
Emotional 0.00/−0.13 56.7 (28.2) 59.7 (15.8) 87.5 (12.9) 69.4 (27.6)* 69.4 (19.2) 88.4 (12.1) 70.6 (29.7)* 73.6 (13.2)*
Cognitive 0.37/0.17 55.6 (18.6) 59.7 (19.4) 96.9 (6.7) 65.6 (21.3)* 62.5 (19.0) 96.9 (6.7) 70.0 (28.9) 70.8 (14.4)
Social 0.63/0.64 53.3 (24.6) 68.1 (26.1) 99.0 (4.2) 71.1 (28.5)** 69.4 (24.5) 96.9 (9.1) 81.1 (28.1)*** 79.2 (17.6)
Global QoL 0.32/0.39 61.7 (23.1) 68.1 (15.6) 82.8 (15.1) 71.7 (22.0)* 71.5 (14.8) 85.4 (13.8) 73.9 (20.4)* 72.2 (13.9)
Fatigue 0.08/0.53 51.1 (27.1) 45.8 (19.0) 22.9 (20.1) 42.2 (23.5) 38.9 (17.9) 14.6 (14.8) 42.2 (28.1) 50.0 (26.6)
Distress (K10) 0.38/0.10 21.2 (7.0) 20.8 (5.2) 12.6 (2.6) 17.9 (7.4)** 19.8 (4.5) 12.2 (2.1) 18.4 (10.4) 19.3 (3.1)
Benefit finding 0.48/0.06 58.1 (13.8) 65.6 (12.2) 64.7 (9.4) 64.7 (10.0) 60.8 (16.7) 67.4 (11.0)
CSE 0.13/0.18 39.1 (12.3) 43.6 (8.5) 42.3 (12.6) 43.8 (8.2) 47.0 (9.7)*** 46.0 (5.7)
Illness perceptions (BIPQ) 0.36/0.45 45.9 (10.3) 43.1 (11.4) 49.3 (12.4) 37.4 (13.2)* 38.5 (9.5) 40.0 (9.0)** 35.6 (18.0)*** 37.7 (11.3)

p < 0.10, *p < 0.05, **p < 0.01, ***p < 0.001 for within-group comparison to Time 1.

Higher scores indicate better QoL for all QLQ–C30 measures except fatigue; more benefit finding; and better CSE. Lower scores indicate less QLQ–C30 fatigue, less distress on K10 and more functional illness perceptions. dInt−Wait = effect size for Intervention improvement corrected for Waitlist improvement. Effect sizes associated with statistically significant interactions for RCT participants (p < 0.05) are shown in bold text; effect sizes associated with interaction trends (p < 0.10) are underlined.